Satellos Bioscience Inc · TSX:MSCL

Satellos Bioscience — 30th Annual PPMD Conference 2024

12 slides from Satellos Bioscience's conference presentation, Jun 29, 2024

  1. Slide 1: Muscle regeneration: the next horizon

    30th Annual PPMD Conference Orlando, Florida | June 29, 2024 Muscle regeneration: the next horizon TM

  2. Slide 2: Legal Disclaimers

    Legal Disclaimers Certain statements in this presentation are “forward-looking statements” under applicable securities laws. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performa

  3. Slide 3: Satellos is based on a landmark discovery

    Satellos is based on a landmark discovery What this means for patients Duchenne is also a stem cell disease  Potential for a new treatment intended to bring muscle back New muscle cells are not being created as needed for ongoing fiber repair and regeneration, resulting in muscle being lost. What S

  4. Slide 4: SAT-3247: A pill to regenerate muscle

    SAT-3247: A pill to regenerate muscle 3247 Dystrophin Independent Dystrophin Dependent Oral medicine to restore muscle regeneration Genetic medicines to stabilize muscle fibers 3247 3247 3247 3247 3247 3247 3247 3247 3247 3247 3247 32 3247 3247 3247 3247 actual size 3247 3247 3247 3247 3247 Satellos

  5. Slide 5: Satellos discovery confirmed in Duchenne patients

    Satellos discovery confirmed in Duchenne patients Individual patient biopsies at different ages*  Clinical reports show that Duchenne patients have muscle stem cells  As we discovered in Mdx mice, there are not enough progenitor muscle cells  Thus, muscle fibers cannot repair themselves in respon

  6. Slide 6: Muscle stem cells need a 'signal' from dystrophin to repair and regenerate muscle fibers

    Muscle stem cells need a ‘signal’ from dystrophin to repair and regenerate muscle fibers Dystrophin Signal Present: Dystrophin Signal Missing: Regeneration Occurs Regeneration Impaired Many progenitor Few stem cells to Too few progenitor cells to Surplus of cells to build muscle maintain pool build

  7. Slide 7: Muscle stem cells need a 'signal' from dystrophin to repair and regenerate muscle fibers

    Muscle stem cells need a ‘signal’ from dystrophin to repair and regenerate muscle fibers Dystrophin Signal Present: Dystrophin Signal Missing: Regeneration Occurs Regeneration Impaired Many progenitor Few stem cells to Too few progenitor cells to Surplus of cells to build muscle maintain pool build

  8. Slide 8: SAT-3247 resets progenitor cell production and increases muscle force, a result of regeneration

    SAT-3247 resets progenitor cell production and increases muscle force, a result of regeneration In vitro In vivo (Mdx) MyoReGenXTM(1) 28-day Treatment with SAT-3247 mdx mice n = 10/group Progenitors as measured by 3247 increases progenitors 3247 increases muscle force 1. MyoReGenX is Satellos’ propr

  9. Slide 9: Preliminary SAT-3247 results show improvements in canine model of DMD

    Preliminary SAT-3247 results show improvements in canine model of DMD (interim data from pilot study*) Regenerative status Muscle force 4-months of dosing with SAT-3247 2-months of dosing with SAT-3247 IgG+ve (damage) Hindlimb Forelimb Start of dosing Start of dosing Dosing Dosing Newtons Newtons Ag

  10. Slide 10: SAT-3247 is about to enter clinical trials

    SAT-3247 is about to enter clinical trials SAT-3247 Ph 1a Ph1a IND filing --------------- 1st subject Safety/ PK Ph 2 POC dosed Readout DMD Q3 - 2024 Q4 – 2024 Q1 - 2025 Q2 - 2025 Ph 1a | Safety & PK Ph 1a | Safety & PK & Biomarkers ----------------- ----------------- Healthy Volunteers Duchenne Pat

  11. Slide 11: Satellos has built an outstanding, experienced team to develop SAT-3247

    Satellos has built an outstanding, experienced team to develop SAT-3247 Frank Gleeson, MBA Liz Williams, CPA, CA Philip Lambert, PhD Michael Cross, PhD, MBA Courtney Wells Michael Rudnicki, OC, PhD, FRS Co-Founder & Chief Financial Officer Chief Scientific Officer Chief Business Officer Co-Founder &

  12. Slide 12: REIMAGINE. REGENERATE. REALIZE the next horizon

    REIMAGINE how muscle degeneration is treated. REGENERATE with small molecule medicines. REALIZE the next horizon to improve lives. Thank you to:

Satellos Bioscience — 30th Annual PPMD Conference 2024 on 6ix